Beyond Verbal

Emotion AI and Vocal Biomarkers


NEW: publication of the Mayo Clinic
& Beyond Verbal paper
Discovering vocal biomarkers associated
with Coronary Artery Disease

What are Vocal Biomarkers

#xMed2017 – Beyond Verbal & Mayo Clinic presenting Vocal Biomarkers

Working with leading research institutes around the world, Beyond Verbal is extracting vocal parameters in order to reveal vocal biomarkers – distinct voice features indicating various health conditions.

The ability to extract vocal biomarkers in a nonintrusive, continuous and passive manner has the potential to revolutionize conventional patient care. Beyond Verbal’s AI technology is set to improve traditional and remote healthcare services and create a novel, patient-centric approach. This paradigm shift will be achieved by gathering an additional layer of personal data which can support the tailoring of healthcare services to individual needs – a service which is challenging for all healthcare providers to deliver today.

Download the white paper

Voice Research to Identify New Biomarkers

Coronary Artery Disease (CAD), Mayo Clinic first paper of its kind, globally, discovering vocal biomarkers associated with Coronary Artery Disease

Autism Spectrum Disorder (ASD) – Abnormal Speech Spectrum and Increased pitch variability in young autistic children

Parkinson’s Disease (PD) – Digital voice analysis in Parkinson’s disease Beyond Verbal is the first company to identify vocal biomarkers for physical health conditions as well as neurological disorders.

If you are a scientist in a research center or work at a commercial organization interested in collaboration feel free to visit our website or contact us for more information.

Existing Research Partners:

come visit us

Beyond Verbal Communication, LTD

125 yigal alon street, tel aviv, 67443 israel
o: +972-3-5758775 F: +972-3-5497082

follow us
Talk to us
(we're expert listeners...)
We will be more than happy to take a virtual coffee-break with you!